Arvinas, Inc. (ARVN)
NASDAQ·Healthcare·Biotechnology
$10.19
-0.97%
Mkt Cap $669.22M
Analyst Ratings
Buy
10
Hold
1
Sell
0
Price Target (34 analysts)
$12.50
Range $6.00 – $18.00
Implied Upside
+22.7%
Consensus $12.50 vs current $10.19
NASDAQ·Healthcare·Biotechnology
$10.19
-0.97%
Mkt Cap $669.22M
Buy
10
Hold
1
Sell
0
Price Target (34 analysts)
$12.50
Range $6.00 – $18.00
+22.7%
Consensus $12.50 vs current $10.19